KRAS and pancreatic neoplasm: This is also in line with the recent finding that in pancreatic cancer cells and PDAC cells in particular, mutant KRAS‐driven transcriptional reprogramming results in enhanced macropinocytosis to meet the high tumor metabolic needs.[28]